Abstract
This study aimed to determine the relation between methylene-tetrahydrofolate reductase (MTHFR) gene polymorphism and lung cancer risk and the frequency of this polymorphism. The study involved 64 lung cancer patients (the study group) with definitive diagnosis and 61 noncancerous subjects (the control group). MTHFR C677T and A1298C mutation analysis was made using DNA isolated from peripheric blood and multiplex PCR and reverse hybridization strip test. Eighty-four percent of the patients were male. The age, gender, and history of alcohol use of the patients and control group were statistically similar. While MTHFR 677T and 677C allele frequency was 0.33 and 0.67 in the patients respectively, it was 0.29 and 0.71 in the control group. The frequencies of MTHFR 1298C and 1298A were 0.33 and 0.67 in the patients, and it was 0.31 and 0.69 in the control group respectively. When MTHFR 677TT and 677CT genotypes were compared with 677CC genotype, lung cancer risk was 2.4 times higher in the 677TT genotype. When MTHFR 1298AC and 1298CC genotypes were compared with 1298AA genotype, lung cancer risk was 1.5 times higher in 1298CC genotype. According to the results, allele frequency of homozygote T and C was high in lung cancer patients. It was 3.05 and 1.29 times higher in smokers than in non-smokers, and 3.05 and 1.64 times higher in males than in females; 3.0 and 2.44 times higher in those with non-small cell lung cancer than in those with small-cell lung cancer.
Similar content being viewed by others
References
Spiro SG, Porter JC (2002) Lung cancer—where are we today? Current advances in staging and nonsurgical treatment. Am J Respir Crit Care Med 166:1166–1196
Parkin GM, Pisani P, Ferlay J (1999) Global cancer statistics. CA Cancer J Clin 49:33–64
Postmus PE (1998) Epidemiology of lung cancer. In: Fishman AP, Elias JA, Fishman JA et al (eds) Fishman’s pulmonary diseases and disorders. McGraw Hill Companies, New York, pp 1707–1719
Shields PG (2002) Molecular epidemiology of smoking and lung cancer. Oncogene 21:6870–6876
Spitz MR, Wei Q, Dong Q, Amos CI, Wu X (2003) Genetic susceptibility to lung cancer: the role of DNA damage and repair. Cancer Epidemiol Biomarkers Prev 12:689–698
World Cancer Research Fund, American Institute for Cancer Research Expert Panel (Potter JD, chair) (1997) Food, nutrition and the prevention of cancer: a global perspective. American Institute for Cancer Research, Washington (DC)
Perera FP (1998) Molecular epidemiology of environmental carcinogenesis. Recent Results Cancer Res 154:39–46
Raunio H, Husgafvel-Pursiainen K, Anttila S, Hietanen E, Hirvonen A, Pelkonen O (1995) Diagnosis of polymorphisms in carcinogen activating and inactivating enzymes and cancer susceptibility. Gene 159:113–121
Shen H, Wei Q, Pillow PC, Amos CI, Hong WK, Spitz MR (2003) Dietary folate intake and lung cancer risk in former smokers: a case control analysis. Cancer Epidemiol Biomarkers Prev 12:980–986
Larsson SC, Håkansson N, Giovannucci E, Wolk A (2006) Folate intake and pancreatic cancer incidence: a prospective study of Swedish women and men. J Natl Cancer Inst 98(6):407–413
Schabath MB, Spitz MR, Lerner SP, Pillow PC, Hernandez LM, Delclos GL, Grossman HB, Wu X (2005) Case-control analysis of dietary folate and risk of bladder cancer. Nutr Cancer 53(2):144–151
Shrubsole MJ, Gao YT, Cai Q, Shu XO, Dai Q, Hébert JR, Jin F, Zheng W (2004) MTHFR polymorphisms, dietary folate intake, and breast cancer risk: results from the Shanghai breast cancer study. Cancer Epidemiol Biomarkers Prev 13:190–196
Choi SW, Mason JB (2002) Folate status: effects on pathways of colorectal carcinogenesis. J Nutr 132:2413–2418
Xu WH, Shrubsole MJ, Xiang YB, Cai Q, Zhao GM, Ruan ZX, Cheng JR, Zheng W, Shu XO (2007) Dietary folate intake, MTHFR genetic polymorphisms, and the risk of endometrial cancer among Chinese woman. Cancer Epidemiol Biomarkers Prev 16(2):281–287
Heijmans BT, Boer JMA, Suchiman HED, Cornelisse CJ, Westendorp RGJ, Kromhout D, Feskens EJM, Slagboom PE (2003) A common variant of the methylenetetrahydrofolate reductase gene (1p36) is associated with an increased risk of cancer. Cancer Res 63:1249–1253
Leclerc D, Sibani S, Rosen R (2005) Molecular biology of methylenetetrahydrofolate reductase (MTHFR) and overview of mutations/polymorphisms. In: Ueland PM, Rozen R (eds) MTHFR polymorphisms and disease. Landes Bioscience, Texas, USA, pp 1–20
Robien K, Ulrich CM (2003) 5, 10-Methylenetetrahydrofolate reductase polymorphisms and leukemia risk: a HuGE minireview. Am J Epidemiol 157:571–582
Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, Boers GJH, den Heijer M, Kluijtmans LAJ, van den Heuve LP, Rozen R (1995) A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 10:111–113
Weisberg I, Tran P, Christensen B, Sibani S, Rozen R (1998) A second genetic polymorphism in methylenetetrahydrofolate reductase (MTHFR) associated with decreased enzyme activity. Mol Genet Metab 64:169–172
Ergul E, Sazci A, Utkan Z, Canturk NZ (2003) Polymorphisms in the MTHFR gene are associated with breast cancer. Tumour Biol 24:286–290
Stolzenberg-Solomon RZ, Qiao YL, Abnet CC, Ratnasinghe DL, Dawsey SM, Dong ZW, Taylor PR, Mark SD (2003) Esophageal and gastric cardia cancer risk and folate- and vitamin B (12)-related polymorphisms in Linxian, China. Cancer Epidemiol Biomarkers Prev 12:1222–1226
Song C, Xing D, Tan W, Wei Q, Lin D (2001) Methylenetetrahydrofolate reductase polymorphisms increase risk of esophageal squamous cell carcinoma in a Chinese population. Cancer Res 61:3272–3275
Siemianowicz K, Gminski J, Garczorz W, Slabiak N, Goss M, Machalski M, Magiera-Molendowska H (2003) Methylenetetrahydrofolate reductase gene C677T and A1298C polymorphisms in patients with small cell and non-small cell lung cancer. Oncol Rep 10:1341–1344
Shen H, Spitz MR, Wang LE, Hong WK, Wei Q (2001) Polymorphisms of methylene-tetrahydrofolate reductase and risk of lung cancer: a case-control study. Cancer Epidemiol Biomarkers Prev 10:397–401
Jeng YL, Wu MH, Huang HB, Lin WY, You SL, Chu TY, Chen CJ (2003) The methylenetetrahydrofolate reductase 677C → T polymorphism and lung cancer risk in a Chinese population. Anticancer Res 23:5149–5152
Shi Q, Zhang Z, Li G, Pillow PC, Hernandez LM, Spitz MR, Wei Q (2005) Sex differences in risk of lung cancer associated with methylene-tetrahydrofolate reductase polymorphisms. Cancer Epidemiol Biomarkers Prev 14(6):1477–1484
Suzuki T, Matsuo K, Hiraki A, Saito T, Sato S, Yatabe Y, Mitsudomi M, Hida T, Ueda R, Tajima K (2007) Impact of one-carbon metabolism-related gene polymorphisms on risk of lung cancer in Japan: a case–control study. Carcinogenesis 28(8):1718–1725
Ryberg D, Hewer A, Phillips DH, Haugen A (1994) Different susceptibility to smoking-induced DNA damage among male and female lung cancer atients. Cancer Res 54:5801–5803
Mollerup S, Ryberg D, Hewer A, Phillips DH, Haugen A (1999) Sex differences in lung CYP1A1 expression and DNA adduct levels among lung cancer patients. Cancer Res 59:3317–3320
Cheng YW, Hsieh LL, Lin PP, Chen CP, Chen CY, Lin TS, Su SM (2001) Gender difference in DNA adduct levels among nonsmoking lung cancer patients. Environ Mol Mutagen 37:304–310
Kelemen LE, Anand SS, Hegele RA, Stampferef MJ, Rosnerf B, Willettef WC, Montague PA (2004) Associations of plasma homocysteine and the methylenetetrahydrofolate reductase C677T polymorphism with carotid intima media thickness among South Asian, Chinese and European Canadians. Atherosclerosis 176:361–370
Curtin K, Bigler J, Slattery ML, Caan B, Potter JD, Ulrich CM (2004) MTHFR C677T and A1298C polymorphisms: diet, estrogen, and risk of colon cancer. Cancer Epidemiol Biomarkers Prev 13:285–292
Gemmati D, Ongaro A, Scapoli GL, Porta MD, Tognazzo S, Serino ML, Bona ED (2004) Common gene polymorphisms in the metabolic folate and methylation pathway and the risk of acute lymphoblastic leukemia and non Hodgkin’s lymphoma in adults. Cancer Epidemiol Biomarkers Prev 13:787–794
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Arslan, S., Karadayi, S., Yildirim, M.E. et al. The association between methylene-tetrahydrofolate reductase gene polymorphism and lung cancer risk. Mol Biol Rep 38, 991–996 (2011). https://doi.org/10.1007/s11033-010-0194-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11033-010-0194-z